Plasma erythropoietin levels and acquired cystic disease of the kidney in patients receiving regular haemodialysis treatment
Plasma erythropoietin levels and acquired cystic disease of the kidney in patients receiving regular haemodialysis treatment
复制标题
接受定期血液透析治疗的患者的血浆促红细胞生成素水平和获得性肾脏囊性疾病
DOI：
--
复制
发表时间：
1991
影响因子：
6.5
通讯作者：
J. Walls
中科院分区：
文献类型：
--
作者：
M. Edmunds;M. Devoy;C. Tomson;U. Krishna;A. Clayworth;S. Durrant;J. Feehally;J. Walls
终末期肾衰竭患者的获得性囊性肾病（ACDK）可能与多红细胞血症的发展相关。对17例长期血液透析患者血浆促红细胞生成素水平与ACDK的关系进行了研究。多发肾囊肿患者血浆促红细胞生成素水平明显高于小于5个肾囊肿或无肾囊肿患者。ACDK组血红蛋白有升高趋势，但差异不显著。这些结果表明，肾囊肿的发展导致促红细胞生成素的分泌增加。
Summary Acquired cystic disease of the kidney (ACDK) in patients with end‐stage renal failure can be associated with development of polycythaemia. The relationship between plasma erythropoietin levels and ACDK in 17 patients on long‐term haemodialysis treatment was studied. There was a significantly higher level of plasma erythropoietin in patients with multiple renal cysts than in those patients with less than five cysts or no cysts. Haemoglobin tended to be higher in the ACDK group, but the difference was not significant. These results indicate that the development of renal cysts results in increased secretion of erythropoietin.
长期血液透析患者的红细胞增多。
影响因子：
39.2
作者：
Shalhoub,RJ;Rajan,U;Kim,VV;Goldwasser,E;Kark,JA;Antoniou,LD
通讯作者：
Antoniou,LD
肾脏疾病中肾单位的代谢适应。
影响因子：
19.6
作者：
Klahr,S;Schwab,SJ;Stokes,TJ
通讯作者：
Stokes,TJ